9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma

  1. Ugolkov, A.V.
  2. Bondarenko, G.I.
  3. Dubrovskyi, O.
  4. Berbegall, A.P.
  5. Navarro, S.
  6. Noguera, R.
  7. O'Halloran, T.V.
  8. Hendrix, M.J.
  9. Giles, F.J.
  10. Mazar, A.P.
Journal:
Anti-Cancer Drugs

ISSN: 1473-5741 0959-4973

Year of publication: 2018

Volume: 29

Issue: 8

Pages: 717-724

Type: Article

DOI: 10.1097/CAD.0000000000000652 GOOGLE SCHOLAR

Sustainable development goals